Neighbourly Pharmacy Inc. (TSX: NBLY)
(“
Neighbourly” or the “
Company”),
Canada’s largest and fastest growing network of independent
pharmacies, announced today that the Company has closed its
previously announced public offering (the
“
Offering”) of 5,175,000 subscription receipts of
Neighbourly (the “
Subscription Receipts”) at a
price of $28.95 per Subscription Receipt for aggregate gross
proceeds of approximately $149.8 million, which includes the full
exercise of the over-allotment option by the Underwriters (as
defined below). The Subscription Receipts were offered by way of a
prospectus supplement dated March 14, 2022 to the Company’s short
form base shelf prospectus dated October 19, 2021 in all of the
provinces and territories of Canada. The Offering was completed
through a syndicate of underwriters led by Scotiabank and RBC
Capital Markets (together, the “
Joint
Bookrunners”), and including BMO Nesbitt Burns Inc.,
National Bank Financial Inc., Desjardins Securities Inc., TD
Securities Inc., Cormark Securities Inc. and iA Private Wealth Inc.
(collectively the "
Underwriters”). The
Subscription Receipts are expected to begin trading on the Toronto
Stock Exchange (TSX) on Friday March 18, 2022, under the ticker
symbol “NBLY.R”.
Neighbourly also announced the closing of its
previously announced concurrent private placement (the
"Concurrent Private Placement") of 4,150,000
subscription receipts of Neighbourly (the “Placement
Subscription Receipts”) to an affiliate of Persistence
Capital Partners ("PCP") at a price of $28.95 per
Placement Subscription Receipt for aggregate gross proceeds of
approximately $120 million. Under the Concurrent Private Placement,
Neighbourly also granted PCP the option to acquire up to 622,500
additional Subscription Receipts for a period of 30 days following
the closing of the Concurrent Private Placement, which has not yet
been exercised.
The aggregate net proceeds of the Offering and
the Concurrent Private Placement will be used to finance a portion
of the purchase price and related expenses of its previously
announced proposed acquisition (the “Acquisition”)
of all of the issued and outstanding shares in the capital of the
entity that owns and operates, directly or indirectly through its
subsidiaries, the network of retail pharmacies known as Rubicon
Pharmacies (“Rubicon”).
The net proceeds from the Offering and the
Concurrent Private Placement will be held in escrow pending the
completion of the Acquisition. If the Acquisition is completed on
or prior to 5:00 p.m. on January 10, 2023, the net proceeds will be
released to the Company and the Subscription Receipts and Placement
Subscription Receipts will be exchanged on a one-for-one basis for
common shares of Neighbourly for no additional consideration or
further action together with, without duplication, an amount equal
to any dividends declared by Neighbourly and payable to holders of
common shares of Neighbourly of record as of dates from and
including the closing date of the Offering to but excluding the
date of closing of the Acquisition, less any applicable withholding
taxes.
If the Acquisition is not completed on or prior
to 5:00 p.m. on January 10, 2023, if the purchase agreement with
respect to the Acquisition is terminated in accordance with its
terms or if the Company advises the Joint Bookrunners, PCP and the
subscription receipt agent or announces to the public that it does
not intend to proceed with the Acquisition, the holders of
Subscription Receipts and PCP, as holder of Placement Subscription
Receipts, will receive a cash payment equal to the offering price
of the Subscription Receipts or the Placement Subscription
Receipts, as applicable, plus their pro rata share of the interest
actually earned on the escrowed funds during the term of the escrow
and their pro rata share of the interest that would have been
earned on 50% of the underwriters' fee or capital commitment fee,
as applicable, were such fees included in the escrowed funds. 50%
of the underwriters' fee was paid upon closing of the Public
Offering and the other 50% will be paid upon closing of the
Acquisition. 50% of the capital commitment fee (representing 4% of
the aggregate subscription price in respect of 3,443,122 Placement
Subscription Receipts, representing 9.99% of the issued and
outstanding common shares of Neighbourly on the date of
announcement of the Acquisition) payable under the Concurrent
Private Placement was paid upon closing of the Concurrent Private
Placement and the other 50% will be paid upon closing of the
Acquisition.
The Acquisition remains subject to customary
closing conditions, including regulatory approvals, and is subject
to rights of first refusal (“ROFRs”) in favour of
certain third parties. Closing of the Acquisition is expected to
occur during the first quarter of the Company’s financial year
ending March 25, 2023 (the second quarter of calendar year
2022).
About Neighbourly Pharmacy Inc.
Neighbourly is Canada’s largest and fastest
growing network of community pharmacies. United by their
patient first focus and their role as essential and trusted
healthcare hubs within their communities, Neighbourly’s
pharmacies strive to provide accessible healthcare with a
personal touch. Since 2015, Neighbourly has
expanded its diversified national
footprint to include 271 locations (on a pro forma basis,
after giving effect to the Acquisition), reinforcing the Company’s
reputation as the industry’s acquirer of choice.
For more information, please contact
investorrelations@nbly.ca or visit www.neighbourlypharmacy.ca.
Neither the subscription receipts nor the
underlying Common Shares offered have been, and they will not be,
registered under U.S. Securities Act of 1933, as amended, and such
securities may not be offered or sold in the United States, absent
registration or an applicable exemption from registration. This
news release shall not constitute an offer to sell or the
solicitation of an offer to buy the subscription receipts or the
underlying Common Shares. The offering or sale of the subscription
receipts and the underlying Common Shares shall not be made in any
jurisdiction in which such offer, solicitation or sale would be
unlawful.
Caution Regarding Forward-Looking
Statements
This news release contains “forward-looking
information” and “forward-looking statements” (collectively,
“forward-looking information”) within the meaning of applicable
securities laws. Forward-looking information may relate to our
future financial results and may include information regarding our
financial position, business strategy, growth strategies, financial
results, taxes, dividend policy, plans and objectives. In some
cases, forward-looking information can be identified by the use of
forward-looking terminology such as “expects”, “estimates”,
“outlook”, “forecasts”, “projection”, “prospects”, “intends”,
“anticipates”, “believes”, or variations of such words and phrases
or statements that certain actions, events or results “may”,
“could”, “would”, “might”, “will”, “will be taken”, “occur” or “be
achieved”. In addition, any statements that refer to expectations,
intentions, projections or other characterizations of future events
or circumstances contain forward-looking information. Statements
containing forward-looking information are not historical facts but
instead represent management’s expectations, estimates and
projections regarding future events or circumstances.
Forward-looking information in this news release includes, among
other things, statements relating to the Acquisition, the Offering
and the Concurrent Private Placement and use of proceeds therefrom,
the closing of the Acquisition and timing thereof, the anticipated
sources of financing of the Acquisition, the fact that closing of
the Acquisition is conditional on certain events occurring, and the
receipt of all necessary regulatory and other approvals.
Forward-looking information is necessarily based
on a number of opinions, estimates and assumptions that the Company
considered appropriate and reasonable as of the date such
statements are made in light of its experience and perception of
historical trends, current conditions and expected future
developments. Such estimates and assumptions include assumptions in
respect of our ability to build our market share; our ability to
retain key personnel; our ability to maintain and expand geographic
scope; our ability to execute on our expansion plans; our ability
to continue investing in infrastructure to support our growth; our
ability to obtain and maintain existing financing on acceptable
terms; currency exchange and interest rates; the impact of
competition; the changes and trends in our industry or the global
economy; the changes in laws, rules, regulations, and global
standards, the satisfaction of all conditions of closing and the
successful completion of the Acquisition within the anticipated
timeframe, including receipt of regulatory and other required
approvals and waivers of ROFRs; the estimated purchase price of the
Acquisition, including post-closing adjustments and ROFRs; the
receipt of consent of third parties to the change of control
triggered by the Acquisition under relevant agreements and store
leases; the successful and timely integration of Rubicon in the
timeframe anticipated; the realization of the anticipated benefits,
economies of scale, operating efficiencies, costs savings and
synergies of the Acquisition in the timeframe anticipated,
including impacts on growth and accretion in various financial
metrics; and the absence of significant undisclosed costs or
liabilities associated with the Acquisition, are material factors
made in preparing forward-looking information and management’s
expectations.
Further, forward-looking information is subject
to known and unknown risks, uncertainties, assumptions and other
factors that may cause the actual results, level of activity,
performance or achievements to be materially different from those
expressed or implied by such forward-looking information, including
but not limited to risks and uncertainties related to the
Acquisition, including the failure to complete the Acquisition in
all material respects in accordance with the purchase agreement
with respect to the Acquisition; the failure to obtain, in a timely
manner or at all, regulatory and other required approvals and
waivers of ROFRs, or to otherwise satisfy the conditions to the
completion of the Acquisition; necessary borrowings under the
Company’s credit facilities may not be available to fund a portion
of the Acquisition; risks related to increased indebtedness after
completion of the Acquisition; the failure to receive consents of
third parties to the change of control triggered by the Acquisition
under relevant agreements and store leases; the failure to realize
the anticipated benefits, economies of scale, operating
efficiencies, costs savings and synergies of the Acquisition in the
timeframe anticipated, or at all; the materiality of post-closing
adjustments under the Purchase Agreement; the Rubicon business may
be adversely impacted during the pendency of the Acquisition; the
risk of potential unforeseen difficulties in integrating the
Rubicon business into the Company’s systems and operations; risks
related to the dependence of the Company on key employees and the
loss of certain key Rubicon personnel; significant undisclosed
costs or liabilities associated with the Acquisition may be
discovered; risks of reliance on information provided by Rubicon
and the risk of inaccurate or incomplete information, historical
and/or stand-alone financial information may not be representative
of future performance, uncertainty as to expected financial
condition and economic performance following the completion of the
Acquisition, and heightened exposure to regulatory environment in
the Canadian Prairies following the Acquisition; as well as other
factors discussed or referred to in the Company’s Management's
Discussion and Analysis for the 16-week and 40-week periods ended
January 1, 2022 and under the heading “Risk Factors” in the final
long form prospectus dated May 17, 2021 filed in connection with
the initial public offering of Neighbourly, both of which are
available on SEDAR at www.sedar.com under the Company’s profile. If
any of these risks or uncertainties materialize, or if the
opinions, estimates, or assumptions underlying the forward-looking
information prove incorrect, actual results or future events might
vary materially from those anticipated in the forward-looking
information.
Although we have attempted to identify important
risk factors that could cause actual results to differ materially
from those contained in forward-looking information, there may be
other risk factors not presently known to us or that we presently
believe are not material that could also cause actual results or
future events to differ materially from those expressed in such
forward-looking information. There can be no assurance that such
information will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such
information. No forward-looking statement is a guarantee of future
results. Accordingly, you should not place undue reliance on
forward-looking information, which speaks only as of the date made.
The forward-looking information contained in this news release
represents the Company’s expectations as of the date of this news
release (or as the date they are otherwise stated to be made) and
are subject to change after such date. However, the Company
disclaims any intention or obligation or undertaking to update or
revise any forward-looking information whether as a result of new
information, future events or otherwise, except as required under
applicable securities laws in Canada. All of the forward-looking
information contained in this news release is expressly qualified
by the foregoing cautionary statements.
Neighbourly Pharmacy (TSX:NBLY.R)
過去 株価チャート
から 11 2024 まで 12 2024
Neighbourly Pharmacy (TSX:NBLY.R)
過去 株価チャート
から 12 2023 まで 12 2024